Neonates, especially preterm infants, are at high risk for infections due to their underdeveloped immune systems. Gentamicin is chosen for its broad-spectrum activity and rapid bactericidal effects. It is often part of empirical therapy in combination with other antibiotics, such as ampicillin, to cover a wide range of potential pathogens.
